The Sentinel Project on Pediatric Drug-Resistant Tuberculosis releases a guide meant to support the care of pregnant and peripartum people with drug-resistant TB and the neonates born to them.

The Sentinel Project on Pediatric Drug-Resistant Tuberculosis and partners will host a virtual symposium, TB Preventive Therapy as Emergency Response to COVID-19, on 27 January 2021.

The Sentinel Project on Pediatric Drug-Resistant Tuberculosis released its March newsletter with many important updates, including that pediatric formulations of second-line TB drugs are now available.

DR-TB STAT and the Sentinel Project will host a webinar, MDR-TB Treatment with Bedaquiline in Children and Adolescents: Global Recommendations and Program Experience in Belarus on 21 November 2017.

The Sentinel Project will host a webinar, Shortened regimens for children and adolescents with MDR-TB, on 31 August 2017.

DR-TB STAT and the Sentinel Project will host a webinar, MDR-TB Treatment with Bedaquiline in Children and Adolescents: Global Recommendations and Program Experience in Belarus on 26 May 2017.

DR-TB STAT and the Sentinel Project will host a webinar on 7 April 2017, The Time Has Come: The Case for Injectable-Sparing Treatment Regimens for Children with MDR-TB.

The Sentinel Project will hold a webinar on June 7th, from 09:00-10:00 EDT (15:00-16:00 CET).

The Sentinel Project’s Advocacy Task Force has developed Rapid Clinical Advice on the use of new TB drugs bedaquiline and delamanid in children.

The webinar will review: